Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Eveline P. Mauser‐Bunschoten
Sign up to set email alerts
138
Publications
5,222
Citation Statements Received
3,979
Citation Statements Given
How they've been cited
5,042
210
4,982
30
How they cite others
3,507
270
3,655
54
Affiliations
University Medical Center Utrecht
,
Utrecht University
Publications
Order By: Most citations
The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability
Verbruggen
1
,
Nováková
2
,
Wessels
3
et al.
1995
Thromb Haemost
Abstract
Show
668
5
566
0
Get access via publisher
Add to collection
Cite
Bleeding in carriers of hemophilia
Plug
1
,
Mauser‐Bunschoten
2
,
Bröcker‐Vriends
3
et al.
2006
Abstract
Show
371
28
371
4
Get access via publisher
Add to collection
Cite
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial
Collins
1
,
Young
2
,
Knobe
3
et al.
2014
Abstract
Show
188
11
281
0
Get access via publisher
Add to collection
Cite
The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia
Fischer
1
,
van der Bom
2
,
Mauser‐Bunschoten
3
et al.
2002
Abstract
Show
254
10
244
0
Get access via publisher
Add to collection
Cite
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease
de Wee
1
,
Sanders
2
,
Mauser‐Bunschoten
3
et al.
2012
Thromb Haemost
Abstract
Show
125
8
212
2
Get access via publisher
Add to collection
Cite
Prophylactic versus on‐demand treatment strategies for severe haemophilia: a comparison of costs and long‐term outcome
Fischer
1
,
van der Bom
2
,
Molho
3
et al.
2002
Haemophilia
Abstract
Show
201
16
194
3
Get access via publisher
Add to collection
Cite
The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII
Sjamsoedin
1
,
Heijnen
2
,
Mauser‐Bunschoten
3
et al.
1981
N Engl J Med
Abstract
Show
316
6
179
0
Get access via publisher
Add to collection
Cite
Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline
Schutgens
1
,
Tuinenburg
2
,
Roosendaal
3
et al.
2009
Haemophilia
Abstract
Show
75
0
156
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5